CareCloud, Inc. logo

CareCloud, Inc.(CCLD)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 2 days
PROFIT SINCE LAST BUY
-8.33% ▼
LAST CLOSE
$2.42
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CCLD

11/13/2026: CCLD (1-star) has a low Upturn Star Rating. Not recommended to BUY.

CareCloud is a micro-cap healthcare technology company providing cloud-based electronic health records and revenue cycle management solutions primarily to outpatient medical practices. The company's main strengths lie in its integrated product suite and stable recurring revenue model. Its primary investment story centers on organic cross-selling and margin expansion through efficiency initiatives. However, key risks include intense competition from larger health-tech enterprises and execution exposure in small-practice markets. The stock suits value-oriented investors seeking small-cap exposure, provided they closely monitor liquidity and competitive pressures.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitCareCloud offers modest revenue growth rates that appeal more to steady adapters than high-octane growth seekers.
Momentum investorWeak fitThe stock typically exhibits low short-term momentum, making it conditional on a positive Upturn signal.
Value investorStrong fit while signal remains positiveThe stock trades at a relatively low price-to-sales multiple compared to broader technology peers.
Dividend investorWeak fitCareCloud does not currently pay a dividend, prioritizing capital reinvestment instead.
Low-risk investorMixed fitWhile lower beta than the broader market, small-cap liquidity and healthcare sector risks introduce volatility.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highSmall-cap common stock listings can experience sudden price swings based on low trading volume.
Valuation riskLowThe stock trades at modest valuation multiples relative to historical SaaS benchmarks.
Competition risk (AI and enterprise competition)HighLarger health-tech competitors possess superior capital resources to deploy advanced AI platforms.
Business qualityMediumRecurring revenue streams provide stability, but client concentration in small practices limits franchise depth.
Dividend incomeLow / noneIncome-focused investors receive no regular cash distributions.
Execution riskMediumSuccessful integration of acquired entities and cross-selling remain crucial for margin expansion.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 102.97M USD
Price to earnings Ratio 20.17
1Y Target Price 7.33
Price to earnings Ratio 20.17
1Y Target Price 7.33
Volume (30-day avg) 457.0K shares
Beta 1.56
52 Weeks Range 1.67 - 3.81
Updated Date 11/15/2026
52 Weeks Range 1.67 - 3.81
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.12

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Health Information Services

BUY participation
100.0%
Active BUY / eligible
4 / 4
30-Day BUY Count Change
+2

Eligible universe: 4 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -54.5%
Avg. Invested days 16
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
CCLD receives a 4-star rating, supported by solid unit economics, solid company fundamentals, and solid analyst coverage. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
CCLD has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+37.5%) and strong cash generation (FCF margin 17.0%) are partially offset by moderate revenue growth (+8.7%), soft profitability (net margin 9.0%).

Financial Health Rating

★★★★★
CCLD's financial health is supported by solid cash strength, including free-cash-flow generation (17.0% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is CCLD's strongest growth driver at +37.5% FY2025 versus FY2024 (strong, 5 stars). By comparison, while revenue growth (+8.7%, moderate) and free-cash-flow growth (+8.4%, moderate) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 23.2% and approximately 85.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 15.27% supports management-shareholder alignment.

Top 5 Institutional Investors

Vanguard Capital Management, LLC 3.95%
Hillsdale Investment Management Inc. 2.17%
Dimensional Fund Advisors, Inc. 1.56%
Two Sigma Investments LLC 1.36%
American Century Companies Inc 1.16%

Unit Economics (Per $1K Revenue)

★★★★★
CCLD generates approximately $465 of gross profit, $95 of operating income, and $170 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins, cash conversion, and capital efficiency support the rating.

Economic Dimensions

★★★★★
Effective Tax Rate: 1.81%

Quantitative Style Profile

★★★★★
CCLD has a high-quality, liquid profile. Weak momentum is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

Value-OrientedQuality TiltHigh VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Healthcare IT Software & SubscriptionsCloud-based EHR, practice management software, and patient portal subscriptions.Provides recurring software license and subscription revenues from medical practices.
Revenue Cycle Management (RCM) ServicesMedical billing, medical coding, clearinghouse services, and financial analytics.Generates fee-based income tied to the volume and monetary value of processed medical claims.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-05
When Before Market
Estimate 0.12
Actual 0.14

Profitability

Profit Margin 7.36%
Operating Margin (TTM) 9.56%

Management Effectiveness

Return on Assets (TTM) 8.83%
Return on Equity (TTM) 24.02%

Valuation

Trailing PE 20.17
Forward PE 4.76
Enterprise Value 141.35M
Price to Sales(TTM) 0.78
Enterprise Value 141.35M
Price to Sales(TTM) 0.78
Enterprise Value to Revenue 1.08
Enterprise Value to EBITDA 4.74
Shares Outstanding 42.55M
Shares Floating 36.17M
Shares Outstanding 42.55M
Shares Floating 36.17M
Percent Insiders 15.27
Percent Institutions 23.16

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.